Search filters

List of works by Kyoung-Ho Pyo

Activation of the Met kinase confers acquired drug resistance in FGFR-targeted lung cancer therapy

scientific article

Antitumor Activity and Acquired Resistance Mechanism of Dovitinib (TKI258) in RET-Rearranged Lung Adenocarcinoma

scientific article published on 24 July 2015

Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR-cMet Bispecific Antibody, in Diverse Models of EGFR Exon 20 Insertion-Driven NSCLC

scientific article published on 15 May 2020

Comprehensive analysis of the characteristics and treatment outcomes of patients with non-small cell lung cancer treated with anti-PD-1 therapy in real-world practice

scientific article published on 25 March 2019

Dynamic changes in PD-L1 expression and CD8+ T cell infiltration in non-small cell lung cancer following chemoradiation therapy

scientific article published on 01 August 2019

ER2, a novel human anti-EGFR monoclonal antibody inhibit tumor activity in non-small cell lung cancer models.

scientific article published on 27 February 2016

Enhancer remodeling and microRNA alterations are associated with acquired resistance to ALK inhibitors.

scientific article published on 18 April 2018

Establishment of a Conditional Transgenic Mouse Model Recapitulating EML4-ALK-Positive Human Non-Small Cell Lung Cancer.

scientific article published on 8 November 2016

Establishment of a platform of non-small-cell lung cancer patient-derived xenografts with clinical and genomic annotation

scientific article published on 11 August 2018

Exosomes Secreted by Toxoplasma gondii-Infected L6 Cells: Their Effects on Host Cell Proliferation and Cell Cycle Changes

scientific article published on 30 April 2016

Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer

scientific article published on 01 July 2019

Immune adjuvant effect of a Toxoplasma gondii profilin-like protein in autologous whole-tumor-cell vaccination in mice.

scientific article published on 28 September 2016

Involvement of trypsin-digested silk peptides in the induction of RAW264.7 macrophage activation

scientific article published on December 2013

Mouse-human co-clinical trials demonstrate superior anti-tumour effects of buparlisib (BKM120) and cetuximab combination in squamous cell carcinoma of head and neck

scientific article published on 23 September 2020

PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients.

scientific article published on 14 November 2016

Patient-Derived Cells to Guide Targeted Therapy for Advanced Lung Adenocarcinoma

scientific article published on 27 December 2019

Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma

scientific article published on 9 October 2015

Phylogenetic relationships of 3 Korean Neodiplostomum species (Digenea: Neodiplostomidae) based on partial CO1 gene.

scientific article

Prominent IL-12 production and tumor reduction in athymic nude mice after Toxoplasma gondii lysate antigen treatment

scientific article

Promising preclinical platform for evaluation of immuno-oncology drugs using Hu-PBL-NSG lung cancer models

scientific article published on 27 November 2018

STAT6 expression and IL-13 production in association with goblet cell hyperplasia and worm expulsion of Gymnophalloides seoi from C57BL/6 mice

scientific article published on 31 October 2013

Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK-rearranged lung cancer

scientific article published on 21 October 2019

YH25448, an Irreversible EGFR-TKI with Potent Intracranial Activity in EGFR Mutant Non-Small Cell Lung Cancer

scientific article published on 22 January 2019